$ETSY

Silverman Josh sold $3.6M of ETSY

Silverman Josh sold 52,750 shares of ETSY INC (ETSY) at $68.57 ($3.62M total) on 2026-06-01 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Silverman Josh
Published Jun 3, 2026, 8:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 3, 2026, 8:42 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$ETSY
Neutral
medium confidence
Mentioned
$ETSY
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ETSYNeutralLow
01

Why it matters

The disclosed sale can slightly affect short-term sentiment, but the pre-arranged nature makes it less likely to represent new negative information about Etsy’s prospects.

02

Market read

A single insider sale at a disclosed price; potential sentiment drag but low fundamental read-through due to 10b5-1.

03

What to watch

Traders may overreact to insider sales; without accompanying buys, guidance changes, or fundamental news, the signal is usually weak.

Relevance 6/10Novelty 6/10Timing: SEC Form 4 filed June 3; sale executed June 1.

Background

The article is an SEC Form 4 insider transaction disclosure for Etsy, Inc., showing a director’s open-market sale under a Rule 10b5-1 plan.

Company-level read

Ticker impact

$ETSYNeutralMedium confidence
Context

Director Josh Silverman sold 52,750 shares in an open-market transaction disclosed via SEC Form 4 on June 1, 2026.

Expected impact

Likely limited near-term price impact; any effect is more about sentiment than fundamentals.

Evidence & confidence

Form 4 provides a concrete datapoint (sale size and price), but 10b5-1 pre-arrangement typically implies non-informational timing.

Market effects

Minimal; this is company-specific insider activity with no stated operational/sector catalyst.

None indicated.

None indicated.

Counterpoint

Because the sale is under a pre-arranged 10b5-1 plan, the transaction may reflect routine liquidity rather than bearish expectations.

Key entities

  • ETSY

    Issuer of the SEC Form 4 insider transaction; director Josh Silverman sold shares under a 10b5-1 plan.

  • Josh Silverman

    Director who executed the reported open-market sale.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$WMTMed

Retailers Report AI-Driven Sales, Bigger Baskets in Q2 Earnings

Walmart, Amazon, and Target reported Q2 earnings showing AI-driven sales growth. Walmart's eCommerce grew 23%, with AI assistant users spending 40% more. Amazon's Alexa for Shopping saw active users nearly double. Target's digital traffic from AI platforms grew over 3.5x faster than the industry average. Albertsons saw a 10-26% increase in order value with AI tools. Shopify's AI-referred traffic and orders tripled, but AI's impact on discovery-driven retail remains uncertain.

$ETSYHigh

Bank of America Resets Etsy Stock Price Target After Event

Bank of America upgraded Etsy to Buy, raising its price target to $105 from $88, citing structural growth. The bank expects mid-single-digit gross merchandise sales growth, higher profitability, and increased shareholder returns. Etsy's new management team is seen as key to reinvigorating growth. BofA raised its fiscal 2027 estimates for gross merchandise sales, EBITDA, and EPS.

$DEMed

Premarket movers: Deere jumps following upbeat Q3, Wolfspeed plunges

Deere shares rose 5.1% after reporting stronger-than-expected Q3 results, with EPS of $5.10 and net sales of $11B. CrowdStrike fell 2.8% following its CTO's departure. Advance Auto Parts dropped 15.9% due to lower normalized earnings. Etsy gained 3.9% after a BofA upgrade. Ultragenyx surged 11.1% on FDA approval for a gene therapy. Moderna fell 13% after a prior surge. Wolfspeed plunged 10.5% on wider-than-expected Q4 loss. Webull rose 13.8% on strong Q2 results.